Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PLYX will decline by -29.79% over the next 2 Weeks and hit $2.47 by Monday, March 23, 2026. In that time frame, PLYX's share price is expected to range between $1.77 and $3.21.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 23, 2026 | 1.77 | 2.47 | 3.21 |
| Mar 20, 2026 | 0.80 | 1.61 | 2.28 |
| Mar 19, 2026 | 1.12 | 1.83 | 2.59 |
| Mar 18, 2026 | 1.29 | 2.00 | 2.79 |
| Mar 17, 2026 | 1.91 | 2.69 | 3.41 |
| Mar 16, 2026 | 2.26 | 3.01 | 3.72 |
| Mar 13, 2026 | 1.32 | 2.15 | 2.88 |
| Mar 12, 2026 | 1.62 | 2.37 | 3.08 |
| Mar 11, 2026 | 1.78 | 2.53 | 3.26 |
| Mar 10, 2026 | 2.45 | 3.22 | 3.98 |
PLYX shares rose +69.60% in Tuesday, March 10, 2026's trading session, rising from a previous close of $3.52 to move at $5.97. The stock demonstrated notable intraday movement (see PLYX's key stats for a full breakdown), fluctuating between $3.29 and $7.39, a +124.62% trading range. While recent weeks have seen some volatility, PLYX has managed to secure a +141.70% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 24.43M shares changing hands, 23.67M more than the previous session. This amounted to $145.83M in total market activity.
Will PLYX Continue Its Downward Trend?
According to analyst ratings and projections for PLYX, Polaryx Therapeutics, Inc. Common Stock shares are anticipated to decrease by -85.93%, potentially reaching $3.21 per share by March 23, 2026. Short-term technical indicators for PLYX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 25 negative trading days within the past 30 sessions. Based on the PLYX stock forecast, now is not the best time to buy PLYX stock because its current trading price is +141.57% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PLYX covering social and institutional perspectives.
PLYX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PLYX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 17.23% to 42.90%) suggest weak bearish momentum with possible fluctuation.Insights into PLYX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Polaryx Therapeutics Common Stock Short-Term Forecasts
PLYX Forecast For Next 5 Days
Our algorithm anticipates Polaryx Therapeutics Common Stock (PLYX) stock could hit $0.00 by Mar 17, 2026. This represents a - fall from today's price, following a - change over the past five days.
PLYX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Polaryx Therapeutics, Inc. Common Stock (PLYX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.19, which would mean a -96.82% decrease from the current price of $5.97. Projections for this period range from a high of $3.95 to a low of $0.00.
PLYX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Polaryx Therapeutics Common Stock's price over the next three months point to a rise. PLYX stock is expected to peak at $35.52 on Mar 17, 2026 before potentially dipping to $0.00 on Jun 10, 2026. On average, PLYX is likely to trade around $9.05 in the coming 90 days.
Polaryx Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Polaryx Therapeutics Common Stock (PLYX) is expected to trade between $0.00 and $35.52 throughout 2026. This would result in an average price of $2.85, potentially offering investors a -52.26% return from current levels.
Polaryx Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Polaryx Therapeutics, Inc. Common Stock (PLYX) is positioned to show a strong performance in March 2026. The price is predicted to move between $16.99 and $35.52, settling at an average of $24.07. This could translate to a +303.18% gain.
April 2026
Based on current market signals, Polaryx Therapeutics, Inc. Common Stock is projected to trend april 2026. We forecast a trading range from $3.06 to $20.08, with a likely average price of $9.01. Investors could expect a potential return of +50.92%.
May 2026
Our predictive algorithms indicate Polaryx Therapeutics, Inc. Common Stock stock may see a shift in May 2026. The expected range spans $0.17–$3.05, with an average target of $1.02. This represents a cautious outlook and a possible loss of -82.91%.
June 2026
Analyzing established trends, Polaryx Therapeutics, Inc. Common Stock looks set to move in June 2026. Projections place the stock between $0.00 and $0.36, averaging around $0.08. This suggests a -98.66% loss from current levels.
July 2026
Market indicators suggest Polaryx Therapeutics, Inc. Common Stock could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $0.16, with a midpoint forecast of $0.01. The stock might deliver a -99.83% loss.
August 2026
Forecasting for August 2026, models estimate that Polaryx Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.14, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
September 2026
According to our latest forecast models, Polaryx Therapeutics, Inc. Common Stock (PLYX) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $0.14, settling at an average of $0.00. This could translate to a -100.00% loss.
October 2026
Based on current market signals, Polaryx Therapeutics, Inc. Common Stock is projected to trend october 2026. We forecast a trading range from $0.00 to $0.13, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
November 2026
Our predictive algorithms indicate Polaryx Therapeutics, Inc. Common Stock stock may see a shift in November 2026. The expected range spans $0.00–$0.13, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
December 2026
Analyzing established trends, Polaryx Therapeutics, Inc. Common Stock looks set to move in December 2026. Projections place the stock between $0.00 and $0.12, averaging around $0.00. This suggests a -100.00% loss from current levels.
January 2027
Market indicators suggest Polaryx Therapeutics, Inc. Common Stock could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.13, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
February 2027
Forecasting for February 2027, models estimate that Polaryx Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.13, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
March 2027
According to our latest forecast models, Polaryx Therapeutics, Inc. Common Stock (PLYX) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.12, settling at an average of $0.00. This could translate to a -100.00% loss.
PLYX's history of dividends and stock splits also plays a role in long-term investor confidence.